Projects per year
Personal profile
Personal profile
Bincy P. Abraham, MD, MS, is professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.
Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.
Research interests
Dr. Abraham is a principal investigator and coinvestigator in several key clinical trials. As author or coauthor, Dr. Abraham’s work has been published in peer-reviewed medical journals including Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases.
External positions
Professor of Clinical Medicine, Weill Cornell Medical College
Feb 1 2016 → …
Research Area Keywords
- Digestive Disorders
- Clinical Translation & Trials
- Clinical Care
Free-text keywords
- Crohn's disease
- Pregnancy & inflammatory bowel disease
- Transition of care in inflammatory bowel disease
- Ulcerative colitis
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
BI 1425-0003 - Phase IIa - Crohn's Study - A Phase IIa, randomised, double-blind, placebo-controlled trial to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BI 706321 orally administered for 12 weeks in patients with Crohn`s Disease (CD) receiving ustekinumab induction treatment
Abraham, B. P., Fan, C. & Glassner, K.
10/3/22 → …
Project: Clinical Trial
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2/11/19 → …
Project: Clinical Trial
-
Corrona Inflammatory Bowel Disease (IBD) Registry
Abraham, B. P., Fan, C. & Glassner, K.
4/3/18 → …
Project: Clinical Trial
-
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
Irani, M., Fan, C., Glassner, K. & Abraham, B. P., 2023, In: Clinical and Experimental Gastroenterology. 16, p. 21-28 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease
Papamichael, K., Vande Casteele, N., Abraham, B. P., Ritter, T., Jain, A. & Cheifetz, A. S., Jan 2023, In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
-
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease
Papamichael, K., Vande Casteele, N., Abraham, B. P., Ritter, T., Jain, A. & Cheifetz, A. S., Oct 2023, In: Clinical Gastroenterology and Hepatology. 21, 11, p. 2978-2980.e2Research output: Contribution to journal › Short survey › peer-review
2 Scopus citations -
The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients
Liu, J. J., Abraham, B. P., Adamson, P., Barnes, E. L., Brister, K. A., Damas, O. M., Glover, S. C., Hooks, K., Ingram, A., Kaplan, G. G., Loftus, E. V., McGovern, D. P. B., Narain-Blackwel, M., Odufalu, F. D., Quezada, S., Reeves, V., Shen, B., Stappenbeck, T. S. & Ward, L., Feb 1 2023, In: Inflammatory bowel diseases. 29, 2, p. 297-307 11 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
Saleh, A., Parsa, S., Garza, M., Quigley, E. M. M. & Abraham, B. P., Jul 1 2023, In: Digestive Diseases. 41, 4, p. 656-665 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations
Prizes
-
HMAI Award for Excellence in Education
Abraham, Bincy P. (Recipient), Apr 1 2023
Prize: Prize (including medals and awards)